These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14612552)

  • 1. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
    Ott HW; Lindner H; Sarg B; Mueller-Holzner E; Abendstein B; Bergant A; Fessler S; Schwaerzler P; Zeimet A; Marth C; Illmensee K
    Cancer Res; 2003 Nov; 63(21):7507-14. PubMed ID: 14612552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
    Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
    Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
    Wahlberg K; Høyer-Hansen G; Casslén B
    Cancer Res; 1998 Aug; 58(15):3294-8. PubMed ID: 9699658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.
    Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M
    Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms.
    Skaggs HS; Saunders BA; Miller RW; Goodrich ST; King MS; Kimbler KD; Branscum AJ; Fung ET; DePriest PD; van Nagell JR; Ueland FR; Baron AT
    Cancer Invest; 2013 Aug; 31(7):433-53. PubMed ID: 23915068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
    Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
    Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors.
    Arts HJ; de Jong S; Hollema H; Ten Hoor KA; de Vries EG; van der Zee AG
    Int J Oncol; 2005 Feb; 26(2):379-84. PubMed ID: 15645122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
    Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
    Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors.
    Nowak M; Glowacka E; Szpakowski M; Szyllo K; Malinowski A; Kulig A; Tchorzewski H; Wilczynski J
    Neuro Endocrinol Lett; 2010; 31(3):375-83. PubMed ID: 20588232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
    Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
    J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
    Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Placental protein 5 and pregnancy zone protein in ovarian cysts and benign cystic ovarian tumors].
    Briese V; Than G; Richter D; Iino K; Seppälä M
    Zentralbl Gynakol; 1988; 110(13):821-3. PubMed ID: 3176735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
    Jackson D; Craven RA; Hutson RC; Graze I; Lueth P; Tonge RP; Hartley JL; Nickson JA; Rayner SJ; Johnston C; Dieplinger B; Hubalek M; Wilkinson N; Perren TJ; Kehoe S; Hall GD; Daxenbichler G; Dieplinger H; Selby PJ; Banks RE
    Clin Cancer Res; 2007 Dec; 13(24):7370-9. PubMed ID: 18094419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients.
    Ibanez de Caceres I; Battagli C; Esteller M; Herman JG; Dulaimi E; Edelson MI; Bergman C; Ehya H; Eisenberg BL; Cairns P
    Cancer Res; 2004 Sep; 64(18):6476-81. PubMed ID: 15374957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Placental protein 12 (PP 12) in cyst and peritoneal fluids and serum samples of patients with ovarian cysts and cystic ovarian tumors].
    Strache RR; Göcze PM; Szábo DG; Büttner HH; Briese V; Kunze M; Csaba IF; Röpcke G
    Zentralbl Gynakol; 1989; 111(11):749-54. PubMed ID: 2781888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours.
    Haeger M; Swahn M; Hahlin M; Horvath G; Bengtsson A
    Anticancer Res; 1996; 16(5B):3189-92. PubMed ID: 8967734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum thrombopoietin levels are higher in patients with ovarian cancer than with benign cysts.
    Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):67-70. PubMed ID: 16359773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-dimensional polyacrylamide gel electrophoresis map of bovine ovarian fluid proteins.
    Mortarino M; Vigo D; Maffeo G; Ronchi S
    Electrophoresis; 1999; 20(4-5):866-9. PubMed ID: 10344260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.